サマリー

臨床試験用消耗品の世界市場 2023-2027
臨床試験用品市場は2022-2027年に1億19452万米ドルの成長が予測され、予測期間中のCAGRは8.48%で加速すると予測されています。この調査レポートは、臨床試験用品市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、バイオ医薬品産業の成長、臨床研究に対する政府の取り組み、地域市場における臨床試験の規制によって牽引されています。
Technavioの臨床試験用品市場は以下のように区分されています：
エンドユーザー別
- 製薬業界
- 生物製剤業界
- 医療機器産業
タイプ別
- フェーズIII
- フェーズ II
- 第IV相およびBE/BA試験
- フェーズI
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間の臨床試験用品市場の成長を促進する主な要因の1つとして、CROSに対する需要の高まりを挙げています。また、製薬業界に焦点を当てた研究の増加やe-臨床試験の需要の高まりは、市場の大きな需要につながる。
本レポートでは、臨床試験用品市場について以下の分野をカバーしています：
- 臨床試験用品市場のサイジング
- 臨床試験用品市場予測
- 臨床試験用品市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、Avantor Inc.、Bionical Emas Group、Bushu Pharmaceuticals Ltd.、Catalent Inc、Clinigen Group Plc、Deutsche Bahn AG、Emsere B.V.、GNH India Pharmaceuticals Ltd.、International Bonded Couriers Inc.、Nuvisan GmbH、Obvio Health USA Inc.、Parexel International Corp.、PHOENIX Pharmahandel GmbH and Co KG、Piramal Enterprises Ltd.、Thermo Fisher Scientific Inc.、Vertical Pharma Resources Ltd.、Ancillare LP、PCI Pharma Services、Precision Medicine Group LLCなどです。また、臨床試験用品市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/clinical-trial-supplies-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global clinical trial supplies market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global clinical trial supplies market 2017 - 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Pharmaceutical industry - Market size and forecast 2022-2027
o Exhibit 34: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
o 6.4 Biologics industry - Market size and forecast 2022-2027
o Exhibit 38: Chart on Biologics industry - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Biologics industry - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Biologics industry - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Biologics industry - Year-over-year growth 2022-2027 (%)
o 6.5 Medical device industry - Market size and forecast 2022-2027
o Exhibit 42: Chart on Medical device industry - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Medical device industry - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Medical device industry - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Medical device industry - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Phase III - Market size and forecast 2022-2027
o Exhibit 52: Chart on Phase III - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Phase III - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Phase III - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
o 7.4 Phase II - Market size and forecast 2022-2027
o Exhibit 56: Chart on Phase II - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Phase II - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Phase II - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
o 7.5 Phase IV and BE/BA studies - Market size and forecast 2022-2027
o Exhibit 60: Chart on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
o 7.6 Phase I - Market size and forecast 2022-2027
o Exhibit 64: Chart on Phase I - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Phase I - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Phase I - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Type
o Exhibit 68: Market opportunity by Type ($ million)
o Exhibit 69: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Ancillare LP
o Exhibit 119: Ancillare LP - Overview
o Exhibit 120: Ancillare LP - Product / Service
o Exhibit 121: Ancillare LP - Key offerings
o 12.4 Avantor Inc.
o Exhibit 122: Avantor Inc. - Overview
o Exhibit 123: Avantor Inc. - Business segments
o Exhibit 124: Avantor Inc. - Key offerings
o Exhibit 125: Avantor Inc. - Segment focus
o 12.5 Bushu Pharmaceuticals Ltd.
o Exhibit 126: Bushu Pharmaceuticals Ltd. - Overview
o Exhibit 127: Bushu Pharmaceuticals Ltd. - Product / Service
o Exhibit 128: Bushu Pharmaceuticals Ltd. - Key offerings
o 12.6 Clinigen Group Plc
o Exhibit 129: Clinigen Group Plc - Overview
o Exhibit 130: Clinigen Group Plc - Product / Service
o Exhibit 131: Clinigen Group Plc - Key offerings
o 12.7 Deutsche Bahn AG
o Exhibit 132: Deutsche Bahn AG - Overview
o Exhibit 133: Deutsche Bahn AG - Business segments
o Exhibit 134: Deutsche Bahn AG - Key news
o Exhibit 135: Deutsche Bahn AG - Key offerings
o Exhibit 136: Deutsche Bahn AG - Segment focus
o 12.8 Emsere B.V
o Exhibit 137: Emsere B.V - Overview
o Exhibit 138: Emsere B.V - Product / Service
o Exhibit 139: Emsere B.V - Key offerings
o 12.9 International Bonded Couriers Inc.
o Exhibit 140: International Bonded Couriers Inc. - Overview
o Exhibit 141: International Bonded Couriers Inc. - Product / Service
o Exhibit 142: International Bonded Couriers Inc. - Key offerings
o 12.10 Nuvisan GmbH
o Exhibit 143: Nuvisan GmbH - Overview
o Exhibit 144: Nuvisan GmbH - Product / Service
o Exhibit 145: Nuvisan GmbH - Key offerings
o 12.11 Obvio Health USA Inc.
o Exhibit 146: Obvio Health USA Inc. - Overview
o Exhibit 147: Obvio Health USA Inc. - Product / Service
o Exhibit 148: Obvio Health USA Inc. - Key offerings
o 12.12 Parexel International Corp.
o Exhibit 149: Parexel International Corp. - Overview
o Exhibit 150: Parexel International Corp. - Product / Service
o Exhibit 151: Parexel International Corp. - Key news
o Exhibit 152: Parexel International Corp. - Key offerings
o 12.13 PCI Pharma Services
o Exhibit 153: PCI Pharma Services - Overview
o Exhibit 154: PCI Pharma Services - Product / Service
o Exhibit 155: PCI Pharma Services - Key offerings
o 12.14 PHOENIX Pharmahandel GmbH and Co KG
o Exhibit 156: PHOENIX Pharmahandel GmbH and Co KG - Overview
o Exhibit 157: PHOENIX Pharmahandel GmbH and Co KG - Product / Service
o Exhibit 158: PHOENIX Pharmahandel GmbH and Co KG - Key news
o Exhibit 159: PHOENIX Pharmahandel GmbH and Co KG - Key offerings
o 12.15 Piramal Enterprises Ltd.
o Exhibit 160: Piramal Enterprises Ltd. - Overview
o Exhibit 161: Piramal Enterprises Ltd. - Product / Service
o Exhibit 162: Piramal Enterprises Ltd. - Key offerings
o 12.16 Precision Medicine Group LLC
o Exhibit 163: Precision Medicine Group LLC - Overview
o Exhibit 164: Precision Medicine Group LLC - Product / Service
o Exhibit 165: Precision Medicine Group LLC - Key offerings
o 12.17 Vertical Pharma Resources Ltd.
o Exhibit 166: Vertical Pharma Resources Ltd. - Overview
o Exhibit 167: Vertical Pharma Resources Ltd. - Product / Service
o Exhibit 168: Vertical Pharma Resources Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global clinical trial supplies market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Biologics industry - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Biologics industry - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Biologics industry - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Biologics industry - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Medical device industry - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Medical device industry - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Medical device industry - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Medical device industry - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Phase III - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Phase III - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Phase III - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Phase III - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Phase II - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Phase II - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Phase II - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Phase II - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Phase IV and BE/BA studies - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Phase IV and BE/BA studies - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Phase I - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Phase I - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Phase I - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Phase I - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Type ($ million)
Exhibits69: Data Table on Market opportunity by Type ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Ancillare LP - Overview
Exhibits120: Ancillare LP - Product / Service
Exhibits121: Ancillare LP - Key offerings
Exhibits122: Avantor Inc. - Overview
Exhibits123: Avantor Inc. - Business segments
Exhibits124: Avantor Inc. - Key offerings
Exhibits125: Avantor Inc. - Segment focus
Exhibits126: Bushu Pharmaceuticals Ltd. - Overview
Exhibits127: Bushu Pharmaceuticals Ltd. - Product / Service
Exhibits128: Bushu Pharmaceuticals Ltd. - Key offerings
Exhibits129: Clinigen Group Plc - Overview
Exhibits130: Clinigen Group Plc - Product / Service
Exhibits131: Clinigen Group Plc - Key offerings
Exhibits132: Deutsche Bahn AG - Overview
Exhibits133: Deutsche Bahn AG - Business segments
Exhibits134: Deutsche Bahn AG - Key news
Exhibits135: Deutsche Bahn AG - Key offerings
Exhibits136: Deutsche Bahn AG - Segment focus
Exhibits137: Emsere B.V - Overview
Exhibits138: Emsere B.V - Product / Service
Exhibits139: Emsere B.V - Key offerings
Exhibits140: International Bonded Couriers Inc. - Overview
Exhibits141: International Bonded Couriers Inc. - Product / Service
Exhibits142: International Bonded Couriers Inc. - Key offerings
Exhibits143: Nuvisan GmbH - Overview
Exhibits144: Nuvisan GmbH - Product / Service
Exhibits145: Nuvisan GmbH - Key offerings
Exhibits146: Obvio Health USA Inc. - Overview
Exhibits147: Obvio Health USA Inc. - Product / Service
Exhibits148: Obvio Health USA Inc. - Key offerings
Exhibits149: Parexel International Corp. - Overview
Exhibits150: Parexel International Corp. - Product / Service
Exhibits151: Parexel International Corp. - Key news
Exhibits152: Parexel International Corp. - Key offerings
Exhibits153: PCI Pharma Services - Overview
Exhibits154: PCI Pharma Services - Product / Service
Exhibits155: PCI Pharma Services - Key offerings
Exhibits156: PHOENIX Pharmahandel GmbH and Co KG - Overview
Exhibits157: PHOENIX Pharmahandel GmbH and Co KG - Product / Service
Exhibits158: PHOENIX Pharmahandel GmbH and Co KG - Key news
Exhibits159: PHOENIX Pharmahandel GmbH and Co KG - Key offerings
Exhibits160: Piramal Enterprises Ltd. - Overview
Exhibits161: Piramal Enterprises Ltd. - Product / Service
Exhibits162: Piramal Enterprises Ltd. - Key offerings
Exhibits163: Precision Medicine Group LLC - Overview
Exhibits164: Precision Medicine Group LLC - Product / Service
Exhibits165: Precision Medicine Group LLC - Key offerings
Exhibits166: Vertical Pharma Resources Ltd. - Overview
Exhibits167: Vertical Pharma Resources Ltd. - Product / Service
Exhibits168: Vertical Pharma Resources Ltd. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations